Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Shaw, Andrew D ^a   Schermer, Carol R ^b   Lobo, Dileep N ^c   Munson, Sibyl H ^d   Khangulov, Victor ^d   Hayashida, David K ^d   Kellum, John A ^e  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b BAXTER HEALTHCARE CORPORATION   (United States)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

^d Boston Strategic Partners Inc   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID PLUS GLUCONATE SODIUM PLUS MAGNESIUM CHLORIDE PLUS POTASSIUM CHLORIDE PLUS SODIUM CHLORIDE; NORMOSOL; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; CRYSTALLOID; ISOTONIC SOLUTION;

ACUTE KIDNEY FAILURE; ADULT; AGED; APACHE; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CATHETER INFECTION; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CRYSTALLOID; DISEASE SEVERITY; ELECTROLYTE DISTURBANCE; ELECTRONIC MEDICAL RECORD; FEMALE; FLUID THERAPY; GASTROINTESTINAL DISEASE; HEART ARRHYTHMIA; HEART DISEASE; HEART STRESS; HOSPITAL READMISSION; HUMAN; INFECTIOUS COMPLICATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; ADOLESCENT; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PROCEDURES; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUID THERAPY; HUMANS; INFUSIONS, INTRAVENOUS; ISOTONIC SOLUTIONS; LENGTH OF STAY; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84942197509     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-1045-z     Document Type: Article

References (37)

1. Awad S, Allison SP, Lobo DN. The history of 0.9 % saline. Clin Nutr. 2008;27:179-88.
2. Williams EL, Hildebrand KL, McCormick SA, Bedel MJ. The effect of intravenous lactated Ringer's solution versus 0.9 % sodium chloride solution on serum osmolality in human volunteers. Anesth Analg. 1999;88:999-1003.
3. Lobo DN, Stanga Z, Simpson JAD, Anderson JA, Rowlands BJ, Allison SP. Dilution and redistribution effects of rapid 2-litre infusions of 0.9 % (w/v) saline and 5 % (w/v) dextrose on haematological parameters and serum biochemistry in normal subjects: a double-blind crossover study. Clin Sci (Lond). 2001;101:173-9.
4. Veech RL. The toxic impact of parenteral solutions on the metabolism of cells: a hypothesis for physiological parenteral therapy. Am J Clin Nutr. 1986;44:519-51.
5. Scheingraber S, Rehm M, Sehmisch C, Finsterer U. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology. 1999;90:1265-70.
6. Ho AM, Karmakar MK, Contardi LH, Ng SS, Hewson JR. Excessive use of normal saline in managing traumatized patients in shock: a preventable contributor to acidosis. J Trauma. 2001;51:173-7.
7. Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, et al. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg. 2001;93:811-6.
8. Lobo DN, Stanga Z, Aloysius MM, Wicks C, Nunes QM, Ingram KL, et al. Effect of volume loading with 1 liter intravenous infusions of 0.9 % saline, 4 % succinylated gelatine (Gelofusine) and 6 % hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers. Crit Care Med. 2010;38:464-70.
9. Reid F, Lobo DN, Williams RN, Rowlands BJ, Allison SP. (Ab)normal saline and physiological Hartmann's solution: a randomized double-blind crossover study. Clin Sci (Lond). 2003;104:17-24.
10. Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9 % saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256:18-24.
11. Cotton BA, Guy JS, Morris Jr JA, Abumrad NN. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock. 2006;26:115-21.
12. Guidet B, Soni N, Della Rocca G, Kozek S, Vallet B, Annane D, et al. A balanced view of balanced solutions. Crit Care. 2010;14:325.
13. Hansen PB, Jensen BL, Skott O. Chloride regulates afferent arteriolar contraction in response to depolarization. Hypertension. 1998;32:1066-70.
14. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest. 1983;71:726-35.
15. McFarlane C, Lee A. A comparison of Plasmalyte 148 and 0.9 % saline for intra-operative fluid replacement. Anaesthesia. 1994;49:779-81.
16. O'Malley CM, Frumento RJ, Hardy MA, Benvenisty AI, Brentjens TE, Mercer JS, et al. A randomized, double-blind comparison of lactated Ringer's solution and 0.9 % NaCl during renal transplantation. Anesth Analg. 2005;100:1518-24.
17. Waters JH, Gottlieb A, Schoenwald P, Popovich MJ, Sprung J, Nelson DR. Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg. 2001;93:817-22.
18. Young JB, Utter GH, Schermer CR, Galante JM, Phan HH, Yang Y, et al. Saline versus Plasma-Lyte A in initial resuscitation of trauma patients: a randomized trial. Ann Surg. 2014;259:255-62.
19. Kellum JA. Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline. Crit Care Med. 2002;30:300-5.
20. Kellum JA, Song M, Almasri E. Hyperchloremic acidosis increases circulating inflammatory molecules in experimental sepsis. Chest. 2006;130:962-7.
21. Kellum JA, Song M, Venkataraman R. Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest. 2004;125:243-8.
22. Zhou F, Peng ZY, Bishop JV, Cove ME, Singbartl K, Kellum JA. Effects of fluid resuscitation with 0.9 % saline versus a balanced electrolyte solution on acute kidney injury in a rat model of sepsis. Crit Care Med. 2014;42:e270-8.
23. McCluskey SA, Karkouti K, Wijeysundera D, Minkovich L, Tait G, Beattie WS. Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesth Analg. 2013;117:412-21.
24. Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9 % saline compared to Plasma-Lyte. Ann Surg. 2012;255:821-9.
25. Shaw AD, Raghunathan K, Peyerl FW, Munson SH, Paluszkiewicz SM, Schermer CR. Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med. 2014;40:1897-905.
26. Raghunathan K, Shaw A, Nathanson B, Stürmer T, Brookhart A, Stefan MS, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med. 2014;42:1585-91.
27. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308:1566-72.
28. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-10.
29. Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1-141.
30. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.
31. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-29.
32. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
33. Parsons LS. Performing a 1: N case-control match on propensity score. Proceedings of the 29th Annual SAS® Users Group International Conference; SAS® Institute Inc.; May 9-12 2004: Montreal. (Available at http://www2.sas.com/proceedings/sugi29/165-29.pdf ).
34. Smith CA, Gosselin RC, Utter GH, Galante JM, Young JB, Scherer LA, et al. Does saline resuscitation affect mechanisms of coagulopathy in critically ill trauma patients? An exploratory analysis. Blood Coagul Fibrinolysis. 2015;26:250-4.
35. Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care. 2010;14:R185.
36. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369:2462-3.
37. National Clinical Guidance Centre. Intravenous fluid therapy in adults in hospital: Clinical Guideline : Methods, evidence and recommendations 2013. Available at https://www.nice.org.uk/guidance/cg174. Accessed Sept 8th 2015.